MVX-ONCO-1 is an anti-cancer therapy based upon triggering the patient's own natural immune response. Using innovative technology to eliminate the cancer cells.
MVX-ONCO-1 consists of a very small device, which is placed underneath the skin with a little incision requiring only one suture and is composed of:
- Irradiated tumor cells from the patient, placed next to the device as the target for the immune response.
- A strong immune-booster (GM-CSF: granulocyte-macrophage colony-stimulating factor), released from an encapsulated, genetically modified cell line
Two main advantages of this therapy:
- All antigens of the cancer are targeted
- Immune booster is delivered continuously over a one week period
MVX-ONCO-1 is indicated to boost the immune system to fight cancer cells